
ABRA kadabra 🪄.. possibly a new drug for COPD 🤞🏾
Treating eosinophilic exacerbations of #asthma and #COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial Read open access here: thelancet.com/journals/lanre… @MonaBafadhel @BTSrespiratory @SanjayResp @kingsmedicine




















